The role of iris biomechanics and sex differences in primary angle-closure glaucoma
Project Number5K99EY035360-02
Contact PI/Project LeaderNAGHIZADEH SAFA, BABAK
Awardee OrganizationGEORGIA INSTITUTE OF TECHNOLOGY
Description
Abstract Text
Primary angle-closure glaucoma (PACG) is a significant cause of irreversible blindness worldwide, affecting c.
17M people. PACG is more prevalent among women; unfortunately, the underlying reasons for this unequal
prevalence are unknown. Factors other than sex, such as anatomical deficits in the anterior chamber, race, and
age, are associated with PACG, with anatomical deficits being the accepted primary clinical criteria used to
assess PACG risk. However, several clinical trials have shown that such anatomical factors are surprisingly poor
predictors of PACG development, indicating the involvement of other unaccounted factors in PACG.
The pathophysiological mechanisms of PACG are closely related to the biomechanics of the iris. Specifically, in
pupillary block (PB), a key feature of PACG, contact between the iris and the lens induces a pressure gradient
between the anterior and posterior chambers. Subsequently, PB leads to occlusion of the outflow pathway (i.e.,
angle closure [AC]) by anterior deformation of the iris, with associated elevation of intraocular pressure and
potential glaucomatous vision loss. We and others have shown that by using pupillary reflexes (e.g., triggered
by light), one can non-invasively evaluate the biomechanical properties of the iris. Interestingly, in patients with
a history of PACG, the iris is stiffer compared to controls. However, the role of iris biomechanics in inducing AC
and PACG is unknown.
Our central hypothesis is that iris biomechanics plays a crucial, unappreciated role in developing PACG, based
on the natural connection between iridial deformations and iridial biomechanical properties. Therefore, this pro-
ject objective is to investigate the role of iris biomechanics in PACG through the evaluation of iridial biome-
chanical properties and mechanics of AC and PB. In addition, we will investigate sex-dependent differences in
iris biomechanics and their potential role in predisposing women to a higher risk of developing PACG.
This project s specific aims (SA) are: SA1 - Investigate sex differences in the biomechanical properties of the iris
using a hybrid in vivo/ex vivo approach in rabbits (K99 mentored phase). SA2 - Investigate sex differences in
biomechanical properties of the human iris using in vivo and ex vivo (cadaver) analyses. SA3 - Investigate bio-
mechanical conditions required to induce AC and PB, and their relation to sex and history of AC (R00). These
studies will provide an improved understanding of the pathophysiology of PACG and a unique opportunity to
combine engineering, basic science, and clinical research to address a significant public health issue.
During the mentored phase, the applicant will learn multiple foundational techniques, including in vivo animal
studies in rabbits, biomechanical analysis of active (muscular) tissue, histology, OCT imaging, and human sub-
ject studies. In addition, he will significantly expand his professional training through various mechanisms. The
skills and techniques learned during the mentored phase will build on the applicant s background in tissue bio-
mechanics and allow him to pursue a successful and impactful independent academic career.
No Sub Projects information available for 5K99EY035360-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K99EY035360-02
Patents
No Patents information available for 5K99EY035360-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K99EY035360-02
Clinical Studies
No Clinical Studies information available for 5K99EY035360-02
News and More
Related News Releases
No news release information available for 5K99EY035360-02
History
No Historical information available for 5K99EY035360-02
Similar Projects
No Similar Projects information available for 5K99EY035360-02